Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:52 PM
Ignite Modification Date:
2025-12-24 @ 3:52 PM
NCT ID:
NCT06065592
Eligibility Criteria:
Inclusion Criteria:
* Individuals of white ethnicity.
* Age between \> 18
* Both males and females.
* Diagnosis of selected cancer type (e.g., colorectal cancer).
* Cancer stage 0/I/II without metastasis or lymph node dissemination at the time of enrollment.
* No previous cancer therapy (radiotherapy, chemotherapy, or immunotherapy) received before study enrollment.
* Unrelated patients.
Exclusion Criteria:
* Cancer stage III/IV.
* History of hematological cancer types or previous cancers, recurrent or relapse.
* Diagnosis of inflammatory bowel diseases.
* Pre-existing cardiovascular diseases or coronary artery diseases.
* Confirmed treated or untreated autoimmune diseases.
* Metabolic disorders, diabetes, or hypertension.
* Neurological diseases.
* Evidence of cardiac, renal, bone, or cerebral damage.
* Presence of more than one type of malignancies.
* Active infections or myositis.
* Familial polyposis.
* Alcohol or smoking habits.
* Colon-affecting food allergies.
* Body mass index (BMI) \>30.
* Significant weight loss within the last 2 years.
* History of abdominal surgeries.
* Pregnancy.
* Related patients.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06065592
Study Brief:
Protocol Section:
NCT06065592